Clinical trials: Bone Atrophy, Alveolar
Alveolar Bone Loss, Maxillary Sinus Disease
Efficacy of Bioactive Glass vs. Xenograft in Maxillary Sinus Augmentation
This randomized controlled study aims to evaluate the clinical, radiographic, and histologic efficacy of using bioactive glass bone graft (UNIGRAFT by Biomed Inc., USA) compared to a conventional xenograft in maxillary sinus…
- Conditions
- Alveolar Bone Loss, Maxillary Sinus Disease, Tooth Loss
- Trial name
- BIOXENO (NCT07125846)
- Testing
- Bioactive Glass Bone Graft (UNIGRAFT), Xenograft Bone Graft (Bio-Oss)
- Volunteers
- 20 people
- Sponsor
- Suez Canal University
Alveolar Bone Atrophy
RCT With 3 Different Biomaterials for Maxillary Sinus Lift
Background: Lateral maxillary sinus augmentation (MSA) is a predictable bone regeneration technique in case of atrophy of the posterior-upper maxilla.
- Trial name
- NCT04506827
- Testing
- Maxillary Sinus Augmentation, Maxillary Sinus Graft with ABBM, Maxillary Sinus Graft with TCP
- Where
- Switzerland
- Volunteers
- 24 people
- Sponsor
- University of Pisa